ACS Meeting Highlights Interface With Biology, Probes National Issues

"So much to do, so little time" appears to sum up the busy program planned for the 209th national meeting and exposition of the American Chemical Society (ACS), to be held April 2-6 in the Convention Center and nearby hotels in Anaheim, Calif. The expected 10,000 participants will have a choice of attending more than 600 technical sessions, and more than 5,000 papers will be presented. The wide range of topics at this spring's meeting indicates the highly interdisciplinary nature of the field a

Written byHoward Goldner
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

"So much to do, so little time" appears to sum up the busy program planned for the 209th national meeting and exposition of the American Chemical Society (ACS), to be held April 2-6 in the Convention Center and nearby hotels in Anaheim, Calif. The expected 10,000 participants will have a choice of attending more than 600 technical sessions, and more than 5,000 papers will be presented.

The wide range of topics at this spring's meeting indicates the highly interdisciplinary nature of the field and the increasing interface of chemistry and biology, according to ACS officials. For example, sessions will cover topics such as contraceptives for the 21st century, revenge of the medfly, anti-cocaine antibodies, microbial polymers, and molecular- level bioremediation.

"Chemistry has the advantage of being a very practical science, and contributes to many other fields, in addition to [providing] a significant amount of basic research of its own," says ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies